Meridian Bioscience (NASDAQ: VIVO)
Some price data may be temporarily unavailable.
Meridian Bioscience Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Meridian Bioscience Company Info
A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.
News & Analysis
Is It Time to Cash In on Meridian Bioscience?
Meridian Bioscience swept past its 52-week high last week. Can this stock go much higher, or is it time to cash out?
Why Meridian Bioscience Stock Shot Up Nearly 13% Today
The coronavirus-focused stock rises notably on news of yet another partnership with a diagnostics company.
This Small-Cap Diagnostics Company Just Joined the Coronavirus Battle
Flu season normally is a busy time for Meridian Bioscience, but this year just took an unexpected turn.
Here's Why Meridian Bioscience, Inc. Stock Is Having a Rough Day
Continued pressure on its diagnostic operations might be more serious than expected.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.